tradingkey.logo
tradingkey.logo
Pesquisar

Cytek Biosciences Inc

CTKB
Adicionar à lista de desejos
4.590USD
+0.010+0.22%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
590.05MValor de mercado
PerdaP/L TTM

Mais detalhes de Cytek Biosciences Inc Empresa

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Informações de Cytek Biosciences Inc

Código da empresaCTKB
Nome da EmpresaCytek Biosciences Inc
Data de listagemJul 23, 2021
CEOJiang (Wenbin)
Número de funcionários648
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 23
Endereço47215 Lakeview Boulevard
CidadeFREMONT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94538
Telefone18779229835
Sitehttps://cytekbio.com
Código da empresaCTKB
Data de listagemJul 23, 2021
CEOJiang (Wenbin)

Executivos da empresa Cytek Biosciences Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
--
--
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%

Perguntas frequentes

Quem são os cinco principais acionistas de Cytek Biosciences Inc?

Os cinco principais acionistas de Cytek Biosciences Inc são: Dr. Wenbin Jiang, Ph.D.

Quantas instituições possuem ações da Cytek Biosciences Inc (CTKB)?

Em 2026Q1, 335 instituições possuíam ações da Cytek Biosciences Inc, com valor de mercado aproximado de 84.13M, representando 65.16% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7060937.00.

Qual é a maior fonte de receita da Cytek Biosciences Inc?

Em 2026Q1, o segmento de negócios Biotechnology, pharmaceutical, distributor and CRO gerou a maior receita para Cytek Biosciences Inc, totalizando 116.73M e representando 57.93% da receita total.